EKF Diagnostics, the point of care diagnostics company, reported that they have completed the acquisition of Quotient Diagnostics (as reported 23 September 2010 edition of Weekly Update). Quotient Diagnostics developed two proprietary diabetes (Hb1Ac) point of care diagnostic products which are complementary to EKF's existing products.
This note was prepared by LCF Research Limited using information provided by the subject company’s management or publically available news sources. No representations are made nor warranties given (express or implied) in relation to accuracy and completeness. This document is not an invitation to invest in the subject company and does not purport to contain all the necessary information that a prospective investor might require. LCF Research Limited recommends prospective investors to conduct their own thorough independent analysis of the subject company and the information contained in this note or referred to above.